Combination of (interferon beta-1b, lopinavir/ritonavir and ribavirin) versus favipiravir in hospitalized patients with non-critical COVID-19: A cohort study

OBJECTIVES: Our study aims at comparing the efficacy and safety of IFN-based therapy (lopinavir/ritonavir, ribavirin, and interferon β-1b) vs. favipiravir (FPV) in a cohort of hospitalized patients with non-critical COVID-19. METHODS: Single center observational study comparing IFN-based therapy (in...

Descripción completa

Detalles Bibliográficos
Autores principales: A. Malhani, Areej, A. Enani, Mushira, Saheb Sharif-Askari, Fatemeh, R. Alghareeb, Mona, T. Bin-Brikan, Roaa, A. AlShahrani, Safar, Halwani, Rabih, Tleyjeh, Imad M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191942/
https://www.ncbi.nlm.nih.gov/pubmed/34111191
http://dx.doi.org/10.1371/journal.pone.0252984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191942/
https://www.ncbi.nlm.nih.gov/pubmed/34111191
http://dx.doi.org/10.1371/journal.pone.0252984

Ejemplares similares